This finding was subsequently validated and extended in a study of Caucasian patients with T2D in whom a higher HDL-C/apoA-I ratio was associated with improved β-cell function and a reduced risk of macrovascular and microangiopathic complications [41]. This evidence concerns the gene APOA1 and type 2 diabetes mellitus.